| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Revenue | ||||||
22,238 | 10,883 | |||||
Operating expenses | ||||||
Research and development | ||||||
82,416 | 45,122 | |||||
General and administrative | ||||||
27,026 | 13,673 | |||||
Total operating expenses | ||||||
109,442 | 58,795 | |||||
Loss from operations | ||||||
-87,204 | -47,912 | |||||
Other income (expense), net: | ||||||
Change in fair value of convertible notes payable | ||||||
9,758 | - | |||||
Interest expense | ||||||
182 | - | |||||
Interest income | ||||||
4,267 | 1,875 | |||||
Total other income (expense), net | ||||||
-5,673 | 1,875 | |||||
Net loss and net loss attributable to common stockholders | ||||||
-92,877 | -46,037 | |||||
Net loss per share attributable to common stockholders- basic and diluted | ||||||
-2.21 | -2.92 | |||||
Weighted average shares of common stock outstanding- basic and diluted | ||||||
41,991 | 15,775 | |||||